D.C.’s New Crime Lab Goes Under the Microscope
By Editorial,
Washington Post Editorial
| 03. 11. 2015
WHAT’S THE point of spending millions of dollars on a crime lab if people don’t trust its findings and won’t use it? That is one question D.C. officials should be asking in light of the unsettling revelation that the U.S. Attorney’s Office has stopped sending DNA evidence to the new Consolidated Forensic Laboratory because it claims there have been serious mistakes. Far more than money is at issue: Forensics plays a key role in determining the guilt or innocence of crime suspects. The concerns of federal prosecutors must be investigated and the integrity of the lab assured.
In January federal prosecutors stopped sending evidence for DNA testing to the crime lab, which is operated by the District’s Department of Forensic Sciences, opting instead to pay for tests at outside labs. The move, as The Post’s Keith L. Alexander reported, came after an outside expert, in a routine review of evidence for an upcoming case, found errors in the interpretation of test results; a subsequent review of 116 cases by two nationally known experts found what federal prosecutors characterized as...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...